Premier Biomedical Inc (BIEI)

PREMIER BIOMEDICAL, INC (BIEI)
http://www.premierbiomedical.com/

AND



PREMIER BIOMEDICAL PAIN MANAGEMENT SOLUTIONS
https://painreliefmeds.com/



CBD for Relieving Your Pain

What's In Your CBD Matters

Consumers have numerous choices for their pain relief needs, so why should they buy from us?

We manufacture our CBD topical patch to the highest Good Manufacturing Practice (GMP) standards.
We use only the highest quality natural, organic, certified non-GMO ingredients to produce the highest quality pain relief product.
Our proprietary blend of essential oils, and natural enhancers, combined with the highest levels of Cannabidiol (CBD) available anywhere, deliver unprecedented long-lasting relief.

CBD is a natural hemp extract which has been found to contain important medicinal properties. There is a growing body of evidence that suggests CBD possesses a strong OPIOID-FREE medical potential for natural relief from:

Knee Pain

Shoulder Pain

Joint Pain

Pain from Arthritis

Muscle Soreness and Tenderness

Headaches

Migraines

Doctors and patients are finding natural CBD to be an effective analgesic for treating mild to moderately severe pain.

Our pain patch delivers up to 96 hours (4 days) of pain relief. Our patent-pending reservoir patch design features a unique barrier between the foam adhesive and the pain relieving ingredients to ensure that the adhesive is not transmitted and absorbed through the skin, as with many competitive patches. Our formulations contain NO PSYCHOACTIVE COMPONENTS, and therefore, will have no effect on drug test results. Our roll-on product consists of the same primary ingredients as contained in our reservoir patch, but in a convenient pocket-size applicator. Our natural enhancers ensure rapid absorption to not only deliver quicker relief, but also reduce the greasy feel.

Additional pain relief products including creams, sprays, gel-pens, and capsules (Pain-Ex^TM) will follow later in the year.

All of our pain relief products are OPIOID-FREE, and 50-STATE LEGAL.

CURRENT DISTRIBUTORS
http://www.premierbiomedical.com/pain-relief-product-distribution-agreements-announced/




PREMIER BIOMEDICAL INC

Premier Biomedical, Inc. has acquired exclusive licenses for patent-pending medications/medical procedures to develop cures for a significant number of the most debilitating and often fatal illnesses affecting mankind: Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer's Disease, Blood Sepsis, Atherosclerosis and Cancer. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. We have initiated the development of potential patient trial application lists. We have a management team with extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment. Our extensive contacts in the medical/pharmaceutical industries will ensure that new developments will achieve maximum visibility and exposure to the market. Transparency and accountability will continue to be ensured via regular issuance of technical progress reports, financials, and investor relations reports to maintain investor enthusiasm.

Potential Cure for Traumatic Brain Injury, Clinical Depression, and Suicidal Ideation (Highlights)
https://www.youtube.com/watch?v=pvXUphEbEuM

INTELLECTUAL PROPERTY

PREMIER BIOMEDICAL HAS OBTAINED EXCLUSIVE WORLD-WIDE LICENSE TO THE PATENTS LISTED BELOW:
SEQUENTIAL EXTRACORPOREAL TREATMENT OF BODILY FLUIDS U.S. PATENT NO. 9,216,386
MEDICATION AND TREATMENT FOR DISEASE U.S.PATENT NO. 8,865,733
UTILIZATION OF STENTS FOR THE TREATMENT OF BLOOD BORNE CARCINOMAS U.S. PATENT NO. 8,758,287
http://www.premierbiomedical.com/science/intellectual-property/

CANCER
http://www.premierbiomedical.com/science/cancer/

FIBROMYALGIA
http://www.premierbiomedical.com/science/fibromyalgia/

MULTIPLE SCLEROSIS (MS)
http://www.premierbiomedical.com/science/fibromyalgia/

BLOOD SEPSIS AND VIREMIA
http://www.premierbiomedical.com/science/blood-sepsis-and-viremia/

UTEPNEWS
University of Texas official news feed:
"Premier Biomedical's breast cancer treatment methodology outperformed chemotherapy and yielded much better results - smaller tumor volume, a much lower mortality rate, and increased subject weight gain...the results were outstandingly successful."

A SCIENTIFIC ROADMAP TO CURE CANCER
http://www.premierbiomedical.com/videos/

 

 

LATEST UPTICK NEWSWIRE FEEDS
https://upticknewswire.com/?s=biei


$BIEI Company Information


Link: http://www.otcmarkets.com/stock/BIEI/company-info
Ticker: $BIEI
OTC Market Place: OTCQB
CIK code: 0001515740
Company name: Premier Biomedical Inc
Company website: http://www.premierbiomedical.com
Incorporated In: NV, USA

Business Description: Premier Biomedical, Inc. has acquired exclusive licenses for patent-pending medications/medical procedures to develop cures for a significant number of the most debilitating and often fatal illnesses affecting mankind: Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer's Disease, Blood Sepsis, Atherosclerosis and Cancer. They have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. They also have initiated the development of potential patient trial application lists. They have a management team with extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment. Their extensive contacts in the medical/pharmaceutical industries will ensure that new developments will achieve maximum visibility and exposure to the market. Transparency and accountability will continue to be ensured via regular issuance of technical progress reports, financials, and investor relations reports to maintain investor enthusiasm.

$BIEI Investor Presentation
http://www.premierbiomedical.com/wp-content/uploads/2015/04/PBI-Intro-Prod-Overview-Pkg-3-section_revApr-15.pdf

ALL TOXIC FUNDING HAS BEEN TERMINATED BY BIEI AS OF 03/28/2017
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11959745

$BIEI Share Structure
 

	Market Value1	$7,424,336	a/o Mar 24, 2017
	Authorized Shares	1,000,000,000	a/o Mar 24, 2017
	Outstanding Shares	447,249,183	a/o Feb 27, 2017
	-Restricted	Not Available
	-Unrestricted	Not Available
	Held at DTC	Not Available
	Float	403,773,213	a/o Feb 27, 2017
	Par Value	0.00001

SIGN UP FOR BIEI COMPANY NEWSLETTER:
https://visitor.r20.constantcontact.com/manage/optin/ea?v=001RasWx_M1beuwZjMbjSeJSNKvyqYPq8Cz